Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Edler

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Mycotoxin Research|September 14, 2018
A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenoneNicole Lorenz, Sven Dänicke, Lutz Edler, et al.
International Journal of Radiation Oncology, Biology, Physics|September 14, 2014
Hypofractionated IMRT of the prostate bed after radical prostatectomy: acute toxicity in the PRIAMOS-1 trialSonja Katayama, Thorbjoern Striecker, Kerstin Kessel, et al.
Statistics in Medicine|September 28, 2011
Considerations on what constitutes a 'qualified statistician' in regulatory guidelinesChristoph Gerlinger, Lutz Edler, Tim Friede, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 2, 2013
Selection of appropriate tumour data sets for Benchmark Dose Modelling (BMD) and derivation of a Margin of Exposure (MoE) for substances that are genotoxic and carcinogenic: considerations of biological relevance of tumour type, data quality and uncertainty assessmentLutz Edler, Andy Hart, Peter Greaves, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 19, 2010
IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytesCorrene A DeCarlo, Alberto Severini, Lutz Edler, et al.
BMC Cancer|November 9, 2015
Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate--first results of the PLATIN 1 trialGregor Habl, Sonja Katayama, Matthias Uhl, et al.
The American Journal of Pathology|March 14, 2002
Lectin histochemistry of resected adenocarcinoma of the lung: helix pomatia agglutinin binding is an independent prognostic factorEckart Laack, Haleh Nikbakht, Anja Peters, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 9, 2008
Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumorsStephanie E Combs, Monika Nagy, Lutz Edler, et al.
Toxicology Letters|May 30, 2009
"ToxRTool", a new tool to assess the reliability of toxicological dataKlaus Schneider, Markus Schwarz, Iris Burkholder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significanceEckart Laack, Haleh Nikbakht, Anja Peters, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Mycotoxin Research|September 14, 2018
A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenoneNicole Lorenz, Sven Dänicke, Lutz Edler, et al.
International Journal of Radiation Oncology, Biology, Physics|September 14, 2014
Hypofractionated IMRT of the prostate bed after radical prostatectomy: acute toxicity in the PRIAMOS-1 trialSonja Katayama, Thorbjoern Striecker, Kerstin Kessel, et al.
Statistics in Medicine|September 28, 2011
Considerations on what constitutes a 'qualified statistician' in regulatory guidelinesChristoph Gerlinger, Lutz Edler, Tim Friede, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 2, 2013
Selection of appropriate tumour data sets for Benchmark Dose Modelling (BMD) and derivation of a Margin of Exposure (MoE) for substances that are genotoxic and carcinogenic: considerations of biological relevance of tumour type, data quality and uncertainty assessmentLutz Edler, Andy Hart, Peter Greaves, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 19, 2010
IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytesCorrene A DeCarlo, Alberto Severini, Lutz Edler, et al.
BMC Cancer|November 9, 2015
Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate--first results of the PLATIN 1 trialGregor Habl, Sonja Katayama, Matthias Uhl, et al.
The American Journal of Pathology|March 14, 2002
Lectin histochemistry of resected adenocarcinoma of the lung: helix pomatia agglutinin binding is an independent prognostic factorEckart Laack, Haleh Nikbakht, Anja Peters, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 9, 2008
Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumorsStephanie E Combs, Monika Nagy, Lutz Edler, et al.
Toxicology Letters|May 30, 2009
"ToxRTool", a new tool to assess the reliability of toxicological dataKlaus Schneider, Markus Schwarz, Iris Burkholder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significanceEckart Laack, Haleh Nikbakht, Anja Peters, et al.
Pageof 13